Louise Haynes to Female
This is a "connection" page, showing publications Louise Haynes has written about Female.
Connection Strength
0.129
-
HIV rapid testing in substance abuse treatment: implementation following a clinical trial. Eval Program Plann. 2011 Nov; 34(4):399-406.
Score: 0.020
-
Disparities in years of potential life lost to Drug-involved overdose deaths in South Carolina. Addict Behav. 2022 03; 126:107181.
Score: 0.010
-
Rates of substance use disorder treatment seeking visits after emergency department-initiated buprenorphine. Am J Emerg Med. 2020 05; 38(5):975-978.
Score: 0.009
-
Association of Substance Use With Hospitalization and Virologic Suppression in a Southern Academic HIV Clinic. Am J Med Sci. 2018 06; 355(6):553-558.
Score: 0.008
-
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
Score: 0.008
-
Substance use and STI acquisition: Secondary analysis from the AWARE study. Drug Alcohol Depend. 2016 Dec 01; 169:171-179.
Score: 0.007
-
Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. JAMA. 2016 Jul 12; 316(2):156-70.
Score: 0.007
-
Substance Use, Depression and Sociodemographic Determinants of HIV Sexual Risk Behavior in Outpatient Substance Abuse Treatment Patients. J Addict Med. 2015 Nov-Dec; 9(6):457-63.
Score: 0.007
-
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23.
Score: 0.006
-
Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence. J Clin Psychiatry. 2014 Jul; 75(7):757-64.
Score: 0.006
-
Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial. JAMA. 2013 Oct 23; 310(16):1701-10.
Score: 0.006
-
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. Drug Alcohol Depend. 2013 Feb 01; 128(1-2):90-7.
Score: 0.006
-
Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012 Jun; 102(6):1160-7.
Score: 0.005
-
Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):313-23.
Score: 0.005
-
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry. 2011 Sep; 50(9):903-14.
Score: 0.005
-
Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr. 2008 Aug 15; 48(5):581-9.
Score: 0.004
-
Improving the transition from residential to outpatient addiction treatment: gender differences in response to supportive telephone calls. Am J Drug Alcohol Abuse. 2008; 34(1):47-59.
Score: 0.004
-
Telephone enhancement of long-term engagement (TELE) in continuing care for substance abuse treatment: a NIDA clinical trials network (CTN) study. Am J Addict. 2007 Nov-Dec; 16(6):495-502.
Score: 0.004